U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Exploring Religious Literacy and Spirituality in Cancer Care” - 07/10/2024
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Exploring Religious Literacy and Spirituality in Cancer Care”
July 10, 2024


Date:
July 10, 2024
Time:
2:00 PM - 3:30 PM ET
Organized By:
Sponsored By:

Image
 Conversations on Cancer: Exploring Religious Literacy and Spirituality in Cancer Care

X (formerly Twitter):  #ConversationsonCancer

Background: 

We spend a lot of time at the FDA working on meeting unmet needs with clinical trials for rare, serious conditions, and life-threatening conditions.  However, all cancer patients – indeed, arguably all patients – also have a need for spiritual care, and research shows that this need is often largely unmet, as well. This edition of the Conversations on Cancer public panel discussion series will start with a brief exploration of the difference between religion and spirituality.  We’ll focus both on patients’ experience with their spirituality during cancer care, and address how the religious literacy and the spirituality of their providers may affect this care.  Of particular interest is how the provision of good spiritual care rests on religious literacy and how increasing religious literacy and spiritual care may increase rapport and foster good communication between providers and patients – especially underserved patients.  Finally, the discussion will touch on how providing better spiritual care benefits not only the patient, but also the burnout-prone provider in today’s healthcare arena.  Resources for patients and for providers will be provided.

Webcast Information: 

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above. 
FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov
 

Back to Top